Site Map
- Gilead just got the first FDA coronavirus treatment approval, but there are still problems
- Living with uncertainty: How leaders at American Airlines, Salesforce, Slack, and Diageo are moving past crisis mode
- Cybersecurity company McAfee shares fall in return to market
- From billion-dollar valuation to bust: Chinese tech unicorn now may be worth just over $1,000
- When second stimulus checks could arrive if Congress reaches a deal
- White House and Twitter deny hacker accessed Trump’s Twitter with password ‘maga2020!’
- Gap and Banana Republic are leaving malls in a big way
- The perils of letting social media titans correct misinformation
- Joe Biden’s tax plan could take a bite out of some small businesses
- Tesla shares pop after a big earnings beat—but its jump to the S&P 500 is hardly a ‘sure thing’
- Bitcoin surges to a 2020 high on PayPal’s embrace
- Employers can’t ignore America’s childcare crisis any longer. How they can fix it
- Justin Simien talks ‘Bad Hair,’ following his genre obsessions, and getting ‘free as hell’ in ’80s horror satire
- Quibi is out. But other companies will still try to build in its place
- Is it time for a regulatory revamp in Congress?
- 76% of American CEOs say they may shrink office space
- How Alicia Boler Davis helped guide Amazon through the pandemic
- Here’s what Amazon’s new Echo speakers are like
- A possible semiconductor shortage looms over Huawei’s new smartphone launch
- What will it take for Beijing to meet its climate goals? Changing how it governs entirely
- I’m shocked—shocked!—that Donald Trump has a Chinese bank account
- As sales dropped, some pharmacies turned to pet meds to stay open
- This mining company is sitting on the world’s biggest deposit of gold
- Target is setting up a reservations system to manage lines on peak holiday shopping days
- Japan set to become the latest country targeting net-zero carbon emissions by 2050
- Some companies are thriving in the pandemic
- National lockdowns return to Europe as COVID-19 numbers soar
- Participant who died in AstraZeneca trial had not been given vaccine
- Global stocks decline as stimulus talks drag on
- Tech veterans say pressure from social media users is key to shift business models and save society
- Careers
- Entertainment
- Venture Capital
- Coronavirus
- Autos
- China
- Markets
- The Travel Industry
- Energy
- A.I.
- Bitcoin
- Food and Drink
- Sports
- Luxury
- Politics
- Economy
- Cybersecurity
- Real Estate
- Russia
- Startups
- Diversity and Inclusion
- Elections
- Inflation
- Chief Executive Officer (CEO)
- Investing
- Earnings
- Social Media
- Taxes
- Climate Change
- IPOs
- Netflix
- Pharmaceutical Industry
- Federal Reserve
- Labor
- Mergers and Acquisitions
- Electric Vehicles
- Private Equity
- Congress
- Housing
- Unemployment
- Remote Work
- Banks
- Interest Rates
- Mental Health
- Layoffs
- Human Resources
- Student Loans and Debt
- Gen Z
- Wealth
- Nutrition